Cargando…
Strains of Faecalibacterium prausnitzii and its extracts reduce blood glucose levels, percent HbA1c, and improve glucose tolerance without causing hypoglycemic side effects in diabetic and prediabetic mice
INTRODUCTION: The commensal bacterium Faecalibacterium prausnitzii is a prominent member of the microbiome of animals and humans, and it plays an important role in several physiological processes. Numerous studies have correlated the reduction of F. prausnitzii abundance with many disease states, in...
Autores principales: | Kallassy, John, Gagnon, Emily, Rosenberg, Dawn, Silbart, Lawrence K, McManus, Simon A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254995/ https://www.ncbi.nlm.nih.gov/pubmed/37277225 http://dx.doi.org/10.1136/bmjdrc-2022-003101 |
Ejemplares similares
-
Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept
por: Bent, Brinnae, et al.
Publicado: (2021) -
Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
por: Ferrannini, Giulia, et al.
Publicado: (2015) -
Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis
por: Jiao, Xiaojuan, et al.
Publicado: (2022) -
Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?
por: Jia, Wenjing, et al.
Publicado: (2010) -
The importance of Faecalibacterium prausnitzii in human health and diseases
por: Parsaei, M., et al.
Publicado: (2021)